FAILURE OF TUBERCULOSIS CHEMOTHERAPY IN A HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENT

被引:18
作者
DYLEWSKI, J
THIBERT, L
机构
[1] ST MARYS HOSP,DIV MICROBIOL & INFECT DIS,MONTREAL,QUEBEC,CANADA
[2] QUEBEC PUBL HLTH LAB,MYCOBACTERIOL LAB,ST ANNE BELLEVUE,QUEBEC,CANADA
关键词
D O I
10.1093/infdis/162.3.778
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:778 / 779
页数:2
相关论文
共 8 条
[1]  
LEVYFREBAULT V, 1987, J CLIN MICROBIOL, V25, P154
[2]  
PABLOSMENDEZ A, 1989, 5TH INT C AIDS MONTR
[3]  
PITCHENIK AE, 1988, CLIN CHEST MED, V9, P425
[4]  
SNIDER DE, 1984, AM REV RESPIR DIS, V130, P1095
[5]   TUBERCULOSIS AS A MANIFESTATION OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) [J].
SUNDERAM, G ;
MCDONALD, RJ ;
MANIATIS, T ;
OLESKE, J ;
KAPILA, R ;
REICHMAN, LB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (03) :362-366
[6]   FAILURE OF OPTIMAL 4-DRUG SHORT-COURSE TUBERCULOSIS CHEMOTHERAPY IN A COMPLIANT PATIENT WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
SUNDERAM, G ;
MANGURA, BT ;
LOMBARDO, JM ;
REICHMAN, LB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (06) :1475-1478
[7]  
1983, AM REV RESPIR DIS, V128, P336
[8]  
1989, MMWR-MORBID MORTAL W, V38, P236